DK0830608T3 - Thromboseriskotest - Google Patents

Thromboseriskotest

Info

Publication number
DK0830608T3
DK0830608T3 DK96919107T DK96919107T DK0830608T3 DK 0830608 T3 DK0830608 T3 DK 0830608T3 DK 96919107 T DK96919107 T DK 96919107T DK 96919107 T DK96919107 T DK 96919107T DK 0830608 T3 DK0830608 T3 DK 0830608T3
Authority
DK
Denmark
Prior art keywords
reagent
protein
plasma
subject
sample
Prior art date
Application number
DK96919107T
Other languages
English (en)
Inventor
Paula A Campbell
Luigi Preda
Original Assignee
Instrumentation Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23939946&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0830608(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Instrumentation Lab Spa filed Critical Instrumentation Lab Spa
Application granted granted Critical
Publication of DK0830608T3 publication Critical patent/DK0830608T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
    • G01N2333/4613—Snake venom
    • G01N2333/462—Snake venom from Agkistrodon sp., e.g. acutase, ACTE
    • G01N2333/4626—Snake venom from Agkistrodon sp., e.g. acutase, ACTE from Agkistrodon contortrix contortrix (copperhead snake); Protac (R)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96463—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Control Of Eletrric Generators (AREA)
DK96919107T 1995-06-09 1996-06-06 Thromboseriskotest DK0830608T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/488,510 US5780255A (en) 1995-06-09 1995-06-09 Protein C pathway screening test
PCT/US1996/009036 WO1996042018A1 (en) 1995-06-09 1996-06-06 Thrombosis risk test

Publications (1)

Publication Number Publication Date
DK0830608T3 true DK0830608T3 (da) 2000-11-20

Family

ID=23939946

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96919107T DK0830608T3 (da) 1995-06-09 1996-06-06 Thromboseriskotest

Country Status (9)

Country Link
US (1) US5780255A (da)
EP (1) EP0830608B1 (da)
JP (1) JP3248621B2 (da)
AT (1) ATE196804T1 (da)
CA (1) CA2224465A1 (da)
DE (1) DE69610558T2 (da)
DK (1) DK0830608T3 (da)
ES (1) ES2152531T3 (da)
WO (1) WO1996042018A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ184995A3 (en) * 1993-01-29 1996-03-13 Bjorn Dahlback Novel anticoagulative cofactor activity
US5708591A (en) * 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6898532B1 (en) 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6321164B1 (en) 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6429017B1 (en) 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
DE19724239A1 (de) * 1997-06-09 1998-12-10 Max Planck Gesellschaft Dysprothrombinämie
US6502040B2 (en) 1997-12-31 2002-12-31 Biomerieux, Inc. Method for presenting thrombosis and hemostasis assay data
AUPP159698A0 (en) * 1998-02-02 1998-02-26 Life Therapeutics Limited Improved blood coagulation test
DE19858278A1 (de) * 1998-12-17 2000-06-21 Dade Behring Marburg Gmbh Verfahren zum Lokalisieren von Defekten im Gerinnungssystem
JP4486260B2 (ja) 1999-02-04 2010-06-23 バイオメリュー・インコーポレイテッド 患者サンプルにおける止血機能不全の存在を予測するための方法および装置
EP1045250A1 (en) * 1999-04-12 2000-10-18 INSTRUMENTATION LABORATORY S.p.A. A global test for evaluating the functionality of the thrombin/antithrombin system
US20020037528A1 (en) * 1999-08-13 2002-03-28 Berg David E. Method for detecting procoagulant genetic and metabolic conditions associated with, and potentially predispositional for, activation of the coagulation response
US7179612B2 (en) 2000-06-09 2007-02-20 Biomerieux, Inc. Method for detecting a lipoprotein-acute phase protein complex and predicting an increased risk of system failure or mortality
US6432658B1 (en) 2000-09-13 2002-08-13 Affinity Biologicals, Inc. Method for measuring antithrombin activity
US20020165149A1 (en) * 2000-12-08 2002-11-07 Kranz David M. Mutated class II major histocompatibility proteins
WO2002052276A2 (en) * 2000-12-19 2002-07-04 Instrumentation Laboratory Company Protein s functional assay
US6855509B2 (en) * 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
RU2722280C1 (ru) * 2019-09-27 2020-05-28 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) Способ прогнозирования тромбоэмболических осложнений у женщин при носительстве мутаций гена протромбина [F2(20210)GA]

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2431342C3 (de) * 1973-07-27 1978-10-26 Behringwerke Ag, 3550 Marburg Verfahren zur Messung des Plasminogengehaltes durch Bestimmung der Bildung von Fibrin in einer Probe
ES431736A1 (es) * 1973-11-13 1977-05-16 Behringwerke Ag Procedimiento para la preparacion de un agente para diagnos-tico para el proposito de efectuar el control de la capaci- dad de coagulacion de la sangre.
NL7508671A (nl) * 1974-07-26 1976-01-28 Behringwerke Ag Werkwijze voor het bepalen van plastiminogeen.
DE2461969A1 (de) * 1974-12-31 1976-07-08 Behringwerke Ag Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen
DE2601372C3 (de) * 1976-01-15 1980-03-27 Behringwerke Ag, 3550 Marburg Verfahren zur Bestimmung von Antithrombin III
DE2757992A1 (de) * 1977-12-24 1979-06-28 Boehringer Mannheim Gmbh Verfahren zur prothrombin-bestimmung
JPS5856695A (ja) * 1981-09-28 1983-04-04 Nitto Boseki Co Ltd 新規なトロンビン測定用基質
CA1213198A (en) * 1982-09-29 1986-10-28 James E. Hughes Diagnostic activated partial thromboplastin reagent
DE3311287A1 (de) * 1983-03-28 1984-10-04 Behringwerke Ag, 3550 Marburg Verfahren zur fotometrischen bestimmung der aktivierten partiellen thromboplastinzeit und reagenz dazu
DE3330699A1 (de) * 1983-08-25 1985-03-07 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur gleichzeitigen bestimmung von fibrinogen und fibrinogen-spaltprodukten im plasma
DE3400434A1 (de) * 1984-01-09 1985-09-26 Behringwerke Ag, 3550 Marburg Bestimmung von fibrin mit fibrin-spezifischen antikoerpern
DE3413311A1 (de) * 1984-04-09 1985-10-17 Behringwerke Ag, 3550 Marburg Reagenz zur bestimmung der thromboplastinzeit
US4849403A (en) * 1985-05-29 1989-07-18 Pentapharm Ag Protein C activator, methods of preparation and use thereof
DE3607559A1 (de) * 1986-03-07 1987-09-10 Boehringer Mannheim Gmbh Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet
US5200322A (en) * 1986-09-19 1993-04-06 Nippon Zoki Pharmaceutical Co., Ltd. Method for assaying protein C and measuring kit for the same
DE3736589A1 (de) * 1987-10-29 1989-05-11 Behringwerke Ag Glutaminhaltige peptide, verfahren zu deren herstellung und verwendung
DE3811647A1 (de) * 1988-04-07 1989-10-26 Behringwerke Ag Verfahren und verpackung enthaltend mittel zur kinetischen bestimmung von faktor xiii
US5206140A (en) * 1988-06-24 1993-04-27 Research Corporation Technologies, Inc. Assay for soluble crosslinked fibrin polymers
IT1230744B (it) * 1989-07-07 1991-10-29 Instrumentation Lab Spa Metodo per la determinazione della attivita' funzionale della proteina s nel plasma umano.
SE464135B (sv) * 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
US5169786A (en) * 1989-12-19 1992-12-08 Ortho Diagnostic Systems, Inc. Method of determining levels of extrinsic and intrinsic clotting factors and protein c
DE4006634A1 (de) * 1990-03-03 1991-09-05 Behringwerke Ag Funktioneller test zur bestimmung der protein s-aktivitaet
WO1993007491A1 (en) * 1991-10-04 1993-04-15 Board Of Regents Of The University Of Nebraska A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
DE4133946A1 (de) * 1991-10-14 1993-04-15 Behringwerke Ag Funktioneller test und reagenz zur bestimmung von fibrinogen
JP2562000B2 (ja) * 1991-11-13 1996-12-11 ダールベツク，ビヨルン 血液凝固疾患の診断方法
FR2689640B1 (fr) * 1992-04-06 1997-08-08 Bio Merieux Procede pour la determination d'une activite proteine c et/ou proteine s dans un echantillon plasmatique.
DK0633473T3 (da) * 1993-06-30 1999-08-09 Stiftung F R Diagnostische For Måling af den aktiverede partielle thromboplastin-tid (APTT) i en reaktion i et enkelt trin
DE4427785A1 (de) * 1994-08-08 1996-02-15 Behringwerke Ag Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
ATE198772T1 (de) * 1994-11-10 2001-02-15 Dade Behring Marburg Gmbh Verfahren zum spezifischen nachweis eines aktivierten gerinnungsfaktors v mit einer erhöhten stabilität gegenüber aktiviertem protein c

Also Published As

Publication number Publication date
EP0830608B1 (en) 2000-10-04
EP0830608A1 (en) 1998-03-25
US5780255A (en) 1998-07-14
MX9709961A (es) 1998-10-31
DE69610558T2 (de) 2001-05-31
ES2152531T3 (es) 2001-02-01
WO1996042018A1 (en) 1996-12-27
ATE196804T1 (de) 2000-10-15
JP3248621B2 (ja) 2002-01-21
JPH11504718A (ja) 1999-04-27
DE69610558D1 (en) 2000-11-09
CA2224465A1 (en) 1996-12-27

Similar Documents

Publication Publication Date Title
DK0830608T3 (da) Thromboseriskotest
US20090087870A1 (en) Hematological assay and kit
ATE315233T1 (de) Verfahren zur bestimmung des antikoagulatorischen potentials einer probe und verfahren zur bestimmung der glykosilierung von thrombomodulin
ES547898A0 (es) Un metodo para determinar la presencia de un componente de coagulacion
DE69108896T2 (de) Verfahren zur bestimmung der konzentration von antikoagulantien.
JPH0368680B2 (da)
AU694931B2 (en) A method for detecting disturbances of the protein C/protein S system
JPS62212569A (ja) タンパク質ｃ―またはタンパク質ｓ―活性を測光により測定する方法
JPH0365958B2 (da)
US5093237A (en) Method and reagent for determining the biological activity of antithrombin iii by measuring coagulation time
US5308756A (en) Protein S chromogenic assay
US5221614A (en) Method and reagent for determining the biological activity of antithrombin III by measuring coagulation time
CA2019872A1 (en) Method and kit for determining the functional activity of protein s in human plasma
US7727736B2 (en) Soluble phospholipids for use in clotting factor assays
US5753510A (en) Calibrator for use in test methods for detecting a defective coagulation factor V
D'Angelo et al. Evaluation of coagulometric assays in the assessment of protein C anticoagulant activity; variable sensitivity of commercial APTT reagents to the cofactor effect of protein S
JPH04350560A (ja) プロテインｓ活性の機能的測定方法
Kirchhof et al. Control of anticoagulant therapy with a chromogenic substrate
Wolf et al. Clinical applications of a direct assay of free protein S antigen using monoclonal antibodies. A study of 59 cases
Tripodi et al. A chromogenic assay of prothrombin compared with coagulation tests during anticoagulant therapy and liver disease
van den Besselaar et al. The relationship between the international normalized ratio and the coumarin-induced coagulation defect
Gaffney et al. Monoclonal antibodies against fibrinogen, fibrin and their fragments
ROSE et al. A comparison of antithrombin III procedures
Francis A new chromogenic assay for the specific determination of prothrombin.
DE3724443A1 (de) Funktioneller test zur bestimmung der protein s-aktivitaet